Soo-Min Jung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Soo-Min Jung has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Sanghoon Lee
Department of Surgery, Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Korea
4 shared publications - Eunyoung Jung
Division of Pediatric Surgery, Department of Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea
3 shared publications - Jeong-Meen Seo
Division of Pediatric Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
3 shared publications - Kyun-Seop Bae
Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
3 shared publications - So Hyun Nam
Department of Surgery, Division of Pediatric Surgery Inje University Busan Paik Hospital Busan South Korea
3 shared publications - Eun Na Kim
Department of Clinical Pharmacology and Therapeutics, Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (11) , e70757
Effect of Food on the Pharmacokinetics, Pharmacodynamics, and Safety of Zastaprazan, a Potassium‐Competitive Acid Blocker, in Healthy Participants
Zastaprazan (JP‐1366) is a novel potassium‐competitive acid blocker characterized by rapid onset and sustained acid suppression. This study aimed to evaluate the effect of food on the pharmacokinetics (PK), pharmacodynamics (PD), and safety of zastaprazan in healthy participants. In this randomized, open‐label, two‐period crossover phase 1 study, 24 healthy participants received a single oral dose of zastaprazan 20 mg under fasted and fed conditions. PK parameters were evaluated using noncompartmental analysis, and PD effects were assessed through continuous intragastric pH monitoring. Under fed conditions, peak exposure (Cmax) decreased (geometric mean ratio [GMR], 0.6997; 90% confidence interval [CI], 0.6292–0.7781), whereas systemic exposure (AUC last ) increased (GMR, 1.3783; 90% CI, 1.2688–1.4973), accompanied by a delayed T max . Despite these PK differences, PD outcomes were comparable between fed and fasted conditions. The percentage of time with intragastric pH ≥ 4 over 24 h was similar under fed and fasted conditions (70.01% vs. 69.19%), with no meaningful differences observed in other pH‐based parameters. Zastaprazan was well tolerated, and no clinically significant safety concerns were identified. Food altered the rate and extent of zastaprazan absorption but did not affect its PD response. These findings indicate that food‐related PK changes do not meaningfully affect PD outcomes and support the administration of zastaprazan without regard to meals. This flexibility may enhance its clinical utility as an acid‐suppressive therapy. Trial Registration: The study was registered at ClinicalTrials.gov (NCT05712681)
- 30 October 2026
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (11) , e70757
Open AccessEffect of Food on the Pharmacokinetics, Pharmacodynamics, and Safety of Zastaprazan, a Potassium‐Competitive Acid Blocker, in Healthy Participants
Zastaprazan (JP‐1366) is a novel potassium‐competitive acid blocker characterized by rapid onset and sustained acid suppression. This study aimed to evaluate the effect of food on the pharmacokinetics (PK), pharmacodynamics (PD), and safety of zastaprazan in healthy participants. In this randomized, open‐label, two‐period crossover phase 1 study, 24 healthy participants received a single oral dose of zastaprazan 20 mg under fasted and fed conditions. PK parameters were evaluated using noncompartmental analysis, and PD effects were assessed through continuous intragastric pH monitoring. Under fed conditions, peak exposure (Cmax) decreased (geometric mean ratio [GMR], 0.6997; 90% confidence interval [CI], 0.6292–0.7781), whereas systemic exposure (AUC last ) increased (GMR, 1.3783; 90% CI, 1.2688–1.4973), accompanied by a delayed T max . Despite these PK differences, PD outcomes were comparable between fed and fasted conditions. The percentage of time with intragastric pH ≥ 4 over 24 h was similar under fed and fasted conditions (70.01% vs. 69.19%), with no meaningful differences observed in other pH‐based parameters. Zastaprazan was well tolerated, and no clinically significant safety concerns were identified. Food altered the rate and extent of zastaprazan absorption but did not affect its PD response. These findings indicate that food‐related PK changes do not meaningfully affect PD outcomes and support the administration of zastaprazan without regard to meals. This flexibility may enhance its clinical utility as an acid‐suppressive therapy. Trial Registration: The study was registered at ClinicalTrials.gov (NCT05712681)
- 28 August 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (11)
Comparative outcomes of laparoscopic inguinal hernia repair in children: With or without peritoneal dissection
- 28 August 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (11)
Comparative outcomes of laparoscopic inguinal hernia repair in children: With or without peritoneal dissection
- Open Access
- 1 January 2025
- Published by XMLink in Translational and Clinical Pharmacology
- Vol. 33 (3) , 145-155
Serum IGF-1 and IGFBP-3 levels in healthy Korean men aged 19–40 years: a cross-sectional analysis of reference ranges and seasonal variation
Serum insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP-3) levels are regulated by growth hormone, nutritional status, and other endocrine factors, and are implicated in aging, metabolic disorders, and malignancies. Establishing appropriate reference ranges for these biomarkers is essential for safety monitoring and pharmacodynamic assessments in clinical trials. Although various detection methods—including enzyme-linked immunosorbent assay, chemiluminescence immunoassay, radioimmunoassay, and immunoradiometric assay (IRMA)—are available, defining reliable reference intervals remains challenging due to variability linked to age, sex, season, and assay methodology. IRMA manufacturers typically provide generalized reference values and recommend that laboratories establish context-specific ranges; however, data from healthy adult populations are limited. We analyzed data from 255 self-reported healthy Korean men aged 19–40 years using the IRMA method and R software. Age-specific reference ranges and standardized centile curves for serum IGF-1 and IGFBP-3 were established. Both biomarkers demonstrated significant seasonal variation, with notable differences observed among spring, autumn, and winter groups. This study presents a method for establishing institution-specific reference ranges and highlights the importance of considering seasonal variations to help reduce unnecessary dropouts during clinical trials.
- 1 January 2025
- Published by XMLink in Translational and Clinical Pharmacology
- Vol. 33 (3) , 145-155
Open AccessSerum IGF-1 and IGFBP-3 levels in healthy Korean men aged 19–40 years: a cross-sectional analysis of reference ranges and seasonal variation
Serum insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP-3) levels are regulated by growth hormone, nutritional status, and other endocrine factors, and are implicated in aging, metabolic disorders, and malignancies. Establishing appropriate reference ranges for these biomarkers is essential for safety monitoring and pharmacodynamic assessments in clinical trials. Although various detection methods—including enzyme-linked immunosorbent assay, chemiluminescence immunoassay, radioimmunoassay, and immunoradiometric assay (IRMA)—are available, defining reliable reference intervals remains challenging due to variability linked to age, sex, season, and assay methodology. IRMA manufacturers typically provide generalized reference values and recommend that laboratories establish context-specific ranges; however, data from healthy adult populations are limited. We analyzed data from 255 self-reported healthy Korean men aged 19–40 years using the IRMA method and R software. Age-specific reference ranges and standardized centile curves for serum IGF-1 and IGFBP-3 were established. Both biomarkers demonstrated significant seasonal variation, with notable differences observed among spring, autumn, and winter groups. This study presents a method for establishing institution-specific reference ranges and highlights the importance of considering seasonal variations to help reduce unnecessary dropouts during clinical trials.
- Open Access
- 1 January 2025
- Published by XMLink in Translational and Clinical Pharmacology
- Vol. 33 (1) , 10-18
The superiority of likelihood-based confidence interval for variance estimation in a single group
Jung SM, et al. Transl Clin Pharmacol. 2025 Mar;33(1):10-18. https://doi.org/10.12793/tcp.2025.33.e1
- 1 January 2025
- Published by XMLink in Translational and Clinical Pharmacology
- Vol. 33 (1) , 10-18
Open AccessThe superiority of likelihood-based confidence interval for variance estimation in a single group
Jung SM, et al. Transl Clin Pharmacol. 2025 Mar;33(1):10-18. https://doi.org/10.12793/tcp.2025.33.e1
- Open Access
- 1 January 2022
- Published by The Korean Society of Radiology in Korean Journal of Radiology
- Vol. 23 (2) , 271-279
Comparison of Clinical and Radiologic Findings Between Perforated and Non-Perforated Choledochal Cysts in Children
Kim YJ, et al. Korean J Radiol. 2022 Jan;23:e3. https://doi.org/10.3348/kjr.2021.0169
- 1 January 2022
- Published by The Korean Society of Radiology in Korean Journal of Radiology
- Vol. 23 (2) , 271-279
Open AccessComparison of Clinical and Radiologic Findings Between Perforated and Non-Perforated Choledochal Cysts in Children
Kim YJ, et al. Korean J Radiol. 2022 Jan;23:e3. https://doi.org/10.3348/kjr.2021.0169
- Open Access
Factors Associated with Failure of Pneumatic Reduction in Children with Ileocolic Intussusception
Intussusception is one of the most common causes of intestinal obstruction in children. Pneumatic reduction is the treatment of choice and has a high success rate. The most common cause of pneumatic reduction failure is the presence of a pathological leading point. We aimed to identify other factors that can lead to pneumatic reduction failure in children with ileocolic intussusception. This was a retrospective study conducted in two centers. Data were collected from January 2013 to December 2014. A total of 156 patients were diagnosed with intussusception and underwent pneumatic reduction, with the exception of one patient with peritonitis. We included patients with ileocolic-type intussusception without apparent pathological leading points. Logistic regression analysis of clinical parameters was performed to identify factors associated with pneumatic reduction failure. Of 156 patients diagnosed with intussusception in both hospitals, 145 were enrolled in the study. The overall efficacy of pneumatic reduction was 85.7%, and surgical reduction was performed in 21 patients. Univariate analysis showed that a high segmented neutrophil count, low hemoglobin level, high body temperature, and higher weight percentile were associated with pneumatic reduction failure. Multivariate analysis showed that a high segmented neutrophil count, low hemoglobin level, and higher weight percentile were significantly associated with pneumatic reduction failure. Pneumatic reduction is safe and effective as a first-line treatment for pediatric intussusception. However, a high segmented neutrophil count, low hemoglobin level, and higher weight percentile are associated with the failure of this treatment.
Open AccessFactors Associated with Failure of Pneumatic Reduction in Children with Ileocolic Intussusception
Intussusception is one of the most common causes of intestinal obstruction in children. Pneumatic reduction is the treatment of choice and has a high success rate. The most common cause of pneumatic reduction failure is the presence of a pathological leading point. We aimed to identify other factors that can lead to pneumatic reduction failure in children with ileocolic intussusception. This was a retrospective study conducted in two centers. Data were collected from January 2013 to December 2014. A total of 156 patients were diagnosed with intussusception and underwent pneumatic reduction, with the exception of one patient with peritonitis. We included patients with ileocolic-type intussusception without apparent pathological leading points. Logistic regression analysis of clinical parameters was performed to identify factors associated with pneumatic reduction failure. Of 156 patients diagnosed with intussusception in both hospitals, 145 were enrolled in the study. The overall efficacy of pneumatic reduction was 85.7%, and surgical reduction was performed in 21 patients. Univariate analysis showed that a high segmented neutrophil count, low hemoglobin level, high body temperature, and higher weight percentile were associated with pneumatic reduction failure. Multivariate analysis showed that a high segmented neutrophil count, low hemoglobin level, and higher weight percentile were significantly associated with pneumatic reduction failure. Pneumatic reduction is safe and effective as a first-line treatment for pediatric intussusception. However, a high segmented neutrophil count, low hemoglobin level, and higher weight percentile are associated with the failure of this treatment.
- Open Access
- 1 January 2019
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 62 (2) , 72-77
Current status and directions of resident education
Jung SM. J Korean Med Assoc. 2019 Feb;62(2):72-77. https://doi.org/10.5124/jkma.2019.62.2.72
- 1 January 2019
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 62 (2) , 72-77
Open AccessCurrent status and directions of resident education
Jung SM. J Korean Med Assoc. 2019 Feb;62(2):72-77. https://doi.org/10.5124/jkma.2019.62.2.72
- Open Access
- 26 June 2018
- Published by Korean Breast Cancer Society in Journal of Breast Disease
- Vol. 6 (1) , 20-24
Clinical Significance of Non-Mass-Like Enhancement of Preoperative Magnetic Resonance Imaging in Breast Cancer Considering Breast-Conserving Surgery
- 26 June 2018
- Published by Korean Breast Cancer Society in Journal of Breast Disease
- Vol. 6 (1) , 20-24
Open AccessClinical Significance of Non-Mass-Like Enhancement of Preoperative Magnetic Resonance Imaging in Breast Cancer Considering Breast-Conserving Surgery
- Open Access
- 1 January 2018
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 61 (11) , 638-642
Medical charges and the cold reality of surgeons of Korea
Jung SM. J Korean Med Assoc. 2018 Nov;61(11):638-642. https://doi.org/10.5124/jkma.2018.61.11.638
- 1 January 2018
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 61 (11) , 638-642
Open AccessMedical charges and the cold reality of surgeons of Korea
Jung SM. J Korean Med Assoc. 2018 Nov;61(11):638-642. https://doi.org/10.5124/jkma.2018.61.11.638